FDA Approves Secnidazole for BV, Trichomoniasis in Adolescents
The FDA has approved secnidazole for the treatment of bacterial vaginosis and trichomoniasis in patients aged 12 years and older. Medscape Medical News …read more
The FDA has approved secnidazole for the treatment of bacterial vaginosis and trichomoniasis in patients aged 12 years and older. Medscape Medical News …read more
“The study findings do not support the use of ivermectin for patients with COVID-19,” study authors conclude. Medscape Medical News …read more